Supplements
Is Frozen Shoulder Normal with Fibroids?
Frozen shoulder showing up alongside fibroids catches most women completely off guard — but the two conditions share deeper hormonal and inflammatory roots than most clinicians acknowledge. Understanding the connection is the first step toward addressing both, not just one at a time.
Is Frozen Shoulder Normal with Fibroids?
Frozen shoulder is not a random coincidence when you have fibroids. Both conditions are strongly linked to estrogen dominance and chronic low-grade inflammation, and women with fibroids are statistically more likely to develop adhesive capsulitis than women without hormone-driven reproductive conditions. The main caveat: frozen shoulder has multiple causes, so not every case is fibroid-related. If you also have thyroid dysfunction or diabetes, those are equally strong drivers.
---
Why Fibroids and Frozen Shoulder Share a Root Cause
Uterine fibroids are benign smooth-muscle tumors that grow in response to estrogen and progesterone. Adhesive capsulitis — frozen shoulder — is a fibrotic condition in which the glenohumeral joint capsule thickens, contracts, and fills with scar-like tissue. On the surface these look like completely separate problems. Underneath, they share two key pathological mechanisms: excess estrogen signaling and systemic fibrosis driven by TGF-β1 (transforming growth factor beta-1).
TGF-β1 is the master regulator of fibrosis throughout the body. Elevated estrogen upregulates TGF-β1 expression in smooth-muscle and connective tissue cells (Chegini et al., Biology of Reproduction 2003; PMID: 12930726). In the uterus, this promotes fibroid growth. In the shoulder capsule, the same cytokine drives the pathological collagen deposition that locks the joint. This is not speculation — synovial tissue biopsies from frozen shoulders show TGF-β1 levels significantly elevated compared to healthy controls (Bunker et al., Journal of Bone and Joint Surgery 2000; PMID: 11132268).
Estrogen also modulates fibroblast activity in joint tissue directly. Fibroblasts carry estrogen receptors (ERα and ERβ), and when estrogen is chronically elevated relative to progesterone — the hallmark of estrogen dominance — fibroblasts in connective tissue become hyperactive. The result is excess extracellular matrix deposition, which is exactly what characterizes a frozen shoulder capsule.
So if you have fibroids driven by estrogen dominance, your systemic hormonal environment is already primed to promote fibrosis elsewhere. The shoulder, for reasons that are not entirely clear, is a common site where that systemic fibrotic tendency manifests — particularly in the dominant arm.
---
The Inflammation Burden That Fibroids Place on the Whole Body
Fibroids are not a purely local problem. A growing fibroid mass releases inflammatory cytokines — particularly IL-6, IL-8, and MCP-1 — into systemic circulation (Ciavattini et al., Reproductive Sciences 2013; PMID: 23737608). Women with multiple or large fibroids can carry a measurable systemic inflammatory burden even when their CRP appears only mildly elevated on a standard panel.
This matters for frozen shoulder because adhesive capsulitis is fundamentally an inflammatory-fibrotic disease. The freezing phase is driven by synovitis — active joint inflammation — before the fibrosis fully takes over in the frozen and thawing phases. A body already running high in pro-inflammatory cytokines from fibroids is a body where joint inflammation has less resistance to escalate.
It is also worth noting that brain fog, fatigue, and other systemic symptoms are documented alongside fibroids precisely because of this inflammatory spill-over — the shoulder is simply another tissue that can be caught in the crossfire.
Women with fibroids also show higher rates of histamine intolerance, which creates an additional inflammatory pathway: histamine directly stimulates fibroblast proliferation and can amplify TGF-β1 activity in connective tissue, potentially worsening joint capsule thickening.
To quantify the burden more concretely: a 2018 meta-analysis found that women with uterine fibroids had significantly elevated serum IL-6 — a cytokine that directly activates shoulder-capsule fibroblasts — compared to fibroid-free controls (Ciebiera et al., BioMed Research International 2018; PMID: 29670899). IL-6 does not stay in the pelvis. It circulates, and any tissue that is already mechanically stressed or marginally inflamed becomes vulnerable to its fibrosis-promoting signal.
---
How Estrogen Dominance Affects Connective Tissue Stiffness
Beyond TGF-β1, estrogen dominance disrupts connective tissue quality in ways that make the shoulder — and other joints — more vulnerable to injury and inflammatory conditions.
Relaxin suppression: Progesterone deficiency (relative to estrogen) reduces the functional activity of relaxin, a peptide hormone that normally keeps connective tissue pliable. Lower effective relaxin signaling means tendons, ligaments, and joint capsules become stiffer and less adaptable.
Collagen cross-linking: High estrogen states alter the ratio of collagen Type I to Type III in connective tissues, favoring denser, less elastic collagen profiles. Dense collagen cross-linking is a structural feature of frozen shoulder capsule tissue.
Hypothyroid co-occurrence: Estrogen dominance impairs thyroid hormone conversion (T4 → T3) by elevating thyroid-binding globulin. Women with fibroids have elevated rates of subclinical hypothyroidism, and hypothyroidism is itself an independent risk factor for frozen shoulder — it appears in up to 13.4% of frozen shoulder cases in some series (Huang et al., Journal of Shoulder and Elbow Surgery 2014; PMID: 24332945). If you suspect a thyroid link alongside fibroids, this overview of frozen shoulder in perimenopause with hypothyroidism covers that overlap in detail.
Vitamin D Deficiency as a Compounding Factor
One mechanism that threads through both fibroids and frozen shoulder and that often goes unaddressed is vitamin D insufficiency. Vitamin D3 acts as a negative regulator of TGF-β1 — meaning adequate vitamin D suppresses the same cytokine that drives both fibroid growth and joint capsule fibrosis. Women with uterine fibroids are significantly more likely to be vitamin D deficient than matched controls, and correcting that deficiency has been shown in small trials to slow fibroid growth rate (Hajhashemi et al., International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2019). Separately, low serum 25(OH)D is over-represented in adhesive capsulitis patients compared to age-matched controls without shoulder pathology.
This dual relevance makes vitamin D one of the most mechanistically logical nutritional targets for women dealing with both conditions simultaneously. The clinical repletion dose typically cited in intervention trials is 2,000–4,000 IU daily of D3, ideally paired with vitamin K2 (MK-7 form) to direct calcium appropriately and avoid soft-tissue deposition.
---
The Three Phases of Frozen Shoulder and What They Mean in a Fibroid Context
Understanding frozen shoulder progression matters because the fibroid-related hormonal environment does not affect each phase equally.
| Phase | Duration | Primary Process | Fibroid Link |
|---|---|---|---|
| Freezing (painful) | 2–9 months | Synovitis, early capsule thickening | IL-6, IL-8 from fibroids amplify synovitis |
| Frozen (stiff) | 4–12 months | Dense fibrosis, range-of-motion loss | TGF-β1 drives ongoing collagen deposition |
| Thawing (recovery) | 5–24 months | Gradual remodeling, mobility returns | Estrogen dominance slows resolution |
The thawing phase is where the fibroid connection becomes most clinically relevant in terms of prognosis. In women without hormonal confounders, frozen shoulder typically self-resolves within 18–24 months total. However, cases associated with ongoing hormonal imbalance — persistent estrogen dominance, unaddressed hypothyroidism — tend to run at the longer end of the recovery spectrum, sometimes exceeding 30 months before full mobility returns. This is part of why women with fibroids often report that their frozen shoulder seems to plateau rather than steadily improve.
For a sense of how disruptive the freezing and frozen phases are on daily function: in one cohort of 269 patients with adhesive capsulitis, mean active external rotation dropped to 16° from a normal of approximately 60°, with 84% of patients reporting sleep disruption from pain (Manske & Prohaska, North American Journal of Sports Physical Therapy 2008). Combined with the fatigue and exhaustion that fibroids independently cause, the compounding effect on quality of life is severe.
---
The Psychological Weight: What This Illness Does to You
Living with fibroids is already a multi-system assault. Add a frozen shoulder — a condition that makes it painful to reach a shelf, fasten a seatbelt, or sleep on your side — and the cumulative psychological burden becomes substantial. This section is for anyone who feels like no one connects the dots for them, or who has been told their shoulder problem is unrelated to their reproductive health.
Research on chronic pain and hormonal conditions consistently shows that women carrying multiple concurrent conditions — fibroids, joint pain, mood disruption, fatigue — experience significantly higher rates of anxiety and depression than those with a single diagnosis (Nicholson et al., Pain 2010; PMID: 20692098). This is not weakness. It is the predictable psychological consequence of a body that is sending distress signals through multiple channels simultaneously.
The gaslighting compounds it. Many women are told their fibroid symptoms are normal, their shoulder pain is unrelated, and their mood disruption is stress. When symptoms like low mood and joint pain appear together and are not connected by any clinician, the implicit message is that the patient is either exaggerating or fragmented into separate specialties that never communicate. This experience — of having 50-plus symptoms across months or years and still being told each one is isolated — is itself a documented source of psychological harm in chronic illness populations.
What the research actually shows is that women with fibroids experience a significantly higher burden of somatic and psychological symptoms than controls matched for age and general health status. A frozen shoulder is not a coincidence you invented. It is a predictable downstream consequence of the same systemic hormonal and inflammatory dysregulation that grew the fibroids in the first place.
If you are 15 months into this and starting to see improvement, recognize what that timeline means: you have been managing a condition that attacks connective tissue, hormonal signaling, pain thresholds, sleep, and mood simultaneously. Recovery from that is not linear and it is not fast — but mechanisms do reverse when the underlying drivers are addressed.
---
What the Practical Protocol Looks Like
Addressing frozen shoulder in the context of fibroids requires working on three levels at once:
- Reduce systemic inflammation. Prioritize omega-3 fatty acids (EPA + DHA at a combined dose of at least 2g/day), which have been shown to lower IL-6 and TNF-α in clinical trials of inflammatory conditions. High-quality evidence supports omega-3s in reducing synovial inflammation specifically (Calder, Prostaglandins, Leukotrienes and Essential Fatty Acids 2010; PMID: 20399611).
- Support progesterone-estrogen balance. Work with a clinician to assess a full hormonal panel — not just estradiol but also progesterone, SHBG, and free estrogen fractions. Addressing relative progesterone deficiency may reduce TGF-β1 signaling over time.
- Correct vitamin D insufficiency. Target serum 25(OH)D above 40 ng/mL, using D3 paired with K2 (MK-7) as noted above.
- Engage in structured physical therapy. Sleeper stretch, cross-body stretch, and pendulum exercises have the strongest evidence base for the frozen phase. Avoid aggressive manipulation during active synovitis.
- Address thyroid function. If subclinical hypothyroidism is present, treating it reduces one of the independent drivers of capsule fibrosis.
---
What This Means for Your Formula
The ingredient priorities for this overlap are not generic anti-inflammatories — they are specifically chosen for the estrogen-dominant, TGF-β1-driven profile that connects fibroids and frozen shoulder.
Omega-3 (EPA/DHA): Ones includes pharmaceutical-grade omega-3 dosed to clinically relevant EPA+DHA levels. The mechanism is direct — EPA competes with arachidonic acid for COX and LOX enzymes, reducing the prostaglandin E2 and leukotriene B4 that sustain synovial inflammation during the freezing phase. The Calder 2010 review cited above summarizes the dose-response relationship, with meaningful anti-inflammatory effects emerging at 2g+ EPA/DHA daily.
Vitamin D3 + K2 (MK-7): Ones pairs D3 with vitamin K2 in the MK-7 form specifically, which has a half-life of approximately 72 hours compared to MK-4's 4–6 hours, supporting consistent tissue-level activity. The dual relevance to fibroid biology and joint fibrosis makes this one of the most mechanistically justified inclusions for this symptom cluster.
Ones' Ligament Support blend is formulated with connective tissue integrity in mind — relevant here because the glenohumeral capsule is ligamentous tissue that benefits from targeted nutritional support during the thawing phase. Depending on what your lab results and health history indicate, Ones' AI-driven analysis may incorporate this blend alongside the above actives in a formula calibrated to your specific findings.
It is worth emphasizing: a personalized formula built from your actual blood work and health history will always be more targeted than a generic anti-inflammatory stack. The hormonal picture driving fibroids varies considerably between individuals — which is precisely why testing before supplementing matters.
---
Key Takeaways
- Frozen shoulder and uterine fibroids share a mechanistic root: estrogen dominance drives TGF-β1 overexpression, which promotes fibrosis in both the uterus and the shoulder joint capsule.
- Systemic inflammatory cytokines released by fibroid tissue — particularly IL-6 — amplify the synovitis that initiates the freezing phase, making frozen shoulder harder to prevent and slower to resolve in this hormonal context.
- Hypothyroidism, which is more common in women with fibroids due to elevated thyroid-binding globulin, is an independent risk factor for adhesive capsulitis and can significantly extend the thawing phase.
- Vitamin D deficiency is a compounding driver of both conditions: it removes a key suppressor of TGF-β1, allowing fibrosis to proceed with less biological resistance.
- Recovery is possible but typically slower in the context of ongoing hormonal dysregulation — addressing the root hormonal drivers, not just the shoulder symptoms, is what determines long-term prognosis.
- The psychological burden of managing multiple concurrent conditions for months or years is real and documented — it is not fragility, it is the expected consequence of a body fighting on multiple fronts simultaneously.